Brought to you by 
Pacific Biosciences gets $100mm--then $20mm and $68mm more
13 Aug 2009
Executive Summary
Pacific Biosciences (genetic testing to predict drug outcomes) has raised $100mm through its Series E venture round. Deerfield Capital Management and Intel Capital co-led the financing and were joined by fellow new investors Morgan Stanley, Redmile Group, T. Rowe Price, and an undisclosed financial institution.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com